Clinical Trial Update: Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced Nephropathy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating acetylcysteine, theophylline, and their combination for prophylaxis of contrast-induced nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy
• Kidney Diseases
• Renal Failure

Drugs mentioned

• Acetylcysteine (Acetylcysteine)
• Acetylcysteine + Theophylline
• Theophylline (Theophylline)

Snippet

Sponsor: Technical University of Munich | Conditions: Contrast Induced Nephropathy, Kidney Diseases | Phase 4 | Status: COMPLETED